Silo Pharma, a US-listed company, announced its first purchase of RSC tokens.
-
最新报道：According to Bijie.com, on October 6th, Silo Pharma, Inc. (NASDAQ: SILO), a diversified, growth-stage biopharmaceutical and cryptocurrency treasury company, announced its first purchase of ResearchCoin (RSC) as part of its expanded digital asset treasury strategy, aiming to capture long-term value from emerging multi-chain opportunities. RSC is the native token of ResearchHub, a decentralized scientific collaboration platform co-founded in 2019 by Coinbase CEO Brian Armstrong. Eric Weisblum, CEO of Silo Pharma, stated, "By investing in RSC, we are participating in the growing decentralized science (DeSci) movement while also diversifying and potentially increasing the value of our assets for our shareholders. This investment in ResearchCoin demonstrates our focus on modernizing scientific collaboration and our support for blockchain-driven innovation as a pillar of biomedical discovery."
下一篇
Bitcoin Depot Enhances Leading Compliance Program with ID Verification and Senior Protections
- Bitcoin Depot has implemented new compliance standards requiring all customers to provide ...
24小时热点
热点专题
407106